Long-term efficacy and safety of zanubrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): final analysis of the Magnolia (BGB-3111-214) Trial
Opat, S. Tedeschi, A. Hu, B. McKay, P. Chan, H. Jin, J. Sun, M. Y. Sobieraj-Teague, M. Zinzani, P. L.
Opat, S.
Tedeschi, A.
Hu, B.
McKay, P.
Chan, H.
Jin, J.
Sun, M. Y.
Sobieraj-Teague, M.
Zinzani, P. L.
Citations
Altmetric:
Abstract
Authors
Opat, S.
Tedeschi, A.
Hu, B.
Linton, Kim M
McKay, P.
Chan, H.
Jin, J.
Sun, M. Y.
Sobieraj-Teague, M.
Zinzani, P. L.
Browett, P. J.
Ke, X. Y.
Portell, C. A.
Thieblemont, C.
Ardeshna, K.
Bijou, F.
Walker, P.
Hawkes, E.
Ho, S. J.
Zhou, K. S.
Liang, Z. Y.
Xu, J. F.
Tankersley, C.
Delarue, R.
Co, M.
Trotman, J.
Tedeschi, A.
Hu, B.
Linton, Kim M
McKay, P.
Chan, H.
Jin, J.
Sun, M. Y.
Sobieraj-Teague, M.
Zinzani, P. L.
Browett, P. J.
Ke, X. Y.
Portell, C. A.
Thieblemont, C.
Ardeshna, K.
Bijou, F.
Walker, P.
Hawkes, E.
Ho, S. J.
Zhou, K. S.
Liang, Z. Y.
Xu, J. F.
Tankersley, C.
Delarue, R.
Co, M.
Trotman, J.
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Opat S, Tedeschi A, Hu B, Linton KM, McKay P, Chan H, et al. Long-Term Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory (R/R) Marginal Zone Lymphoma (MZL): Final Analysis of the Magnolia (BGB-3111-214) Trial. Blood. 2022 Nov;140. PubMed PMID: WOS:000893223200234.